Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

DCOY

Decoy Therapeutics Inc

May 06 • 04:00PM ET

6.01

+0.17 2.91 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: BLRX ADAP AFMD ANAB IMUX EQ AVIR SYBX CLRB

| Held by: MEDX

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-304.79	Insider Own	5.56%	Shs Outstand	0.53M	Perf Week	8.48%
Market Cap	3.20M	Forward P/E	-	EPS next Y	-	Insider Trans	-	Shs Float	0.50M	Perf Month	2.82%
Enterprise Value	-7.51M	PEG	-	EPS next Q	-	Inst Own	1.24%	Short Float	4.65%	Perf Quarter	-20.50%
Income	-12.52M	P/S	-	EPS this Y	-	Inst Trans	1.81%	Short Ratio	0.96	Perf Half Y	-86.16%
Sales	0.00M	P/B	0.54	EPS next Y	-	ROA	-177.82%	Short Interest	0.02M	Perf YTD	-22.81%
Book/sh	11.07	P/C	0.30	EPS next 5Y	-	ROE	-338.31%	52W High	415.80 -98.55%	Perf Year	-95.44%
Cash/sh	20.11	P/FCF	-	EPS past 3/5Y	81.80% 62.32%	ROIC	-212.58%	52W Low	5.15 16.70%	Perf 3Y	-99.77%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.06% 7.72%	Perf 5Y	-99.99%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	77.17%	Oper. Margin	-	ATR (14)	0.49	Perf 10Y	-100.00%
Dividend Ex-Date	-	Quick Ratio	2.13	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	48.10	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.13	EPS Q/Q	90.77%	SMA20	3.44%	Beta	0.38	Target Price	30.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-10.72%	Rel Volume	0.48	Prev Close	5.84
Employees	11	LT Debt/Eq	0.00	Earnings	Mar 30	SMA200	-81.03%	Avg Volume	24.10K	Price	6.01
IPO	Jan 29, 2015	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	11,495	Change	2.91%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)